1.     O'Hare J, Zielinski E, Cheng B, Scherer T, Buettner C. Central endocannabinoid signaling regulates hepatic glucose production and systemic lipolysis. Diabetes; 2011 Apr;60(4):1055-62.

2.    Scherer T, O'Hare J, Diggs-Andrews K, Schweiger M, Cheng B, Lindtner C, Zielinski E, Su K, Dighe S, Milsom T, Puchowicz M, Scheja L, Zechner R, Fisher S, Previs S, Buettner C. Brain insulin controls adipose tissue function. Cell Met 2011 February; 13(2): 183-194.

3.    Scherer T, Buettner C. Yin and Yang of Hypothalamic Insulin and Leptin Signaling in Regulating White Adipose Tissue Metabolism. Reviews in Endocrine and Metabolic Disorders; in press.

4.  Li JH, Gautam D, Han SJ, Guettier JM, Cui Y, Lu H, Deng C, O'Hare J, Jou W, Gavrilova O, Buettner C, Wess J. Hepatic Muscarinic Acetylcholine Receptors are not Critically Involved in Maintaining Glucose Homeostasis in Mice. Diabetes. 2009 Dec;58(12):2776-87. PMID: 19752163

5.     Muzumdar RH, Huffman DM, Atzmon G, Buettner C, Cobb LJ, Fishman S, Budagov T, Cui L, Einstein FH, Poduval A, Hwang D, Barzilai N, Cohen P. Humanin: a novel central regulator of peripheral insulin action. PLoS One. 2009 Jul 22;4(7):e6334.  PMID: 19623253

6.     Scherer T and Buettner C. The dysregulation of the endocannabinoid system in diabesity-a tricky problem. J Mol Med. 2009 Mar 17. PMID: 19290485

7.     Tamma R, Colaianni G, Zhu LL, DiBenedetto A, Greco G, Montemurro G, Patano N, Strippoli M, Vergari R, Mancini L, Colucci S, Grano M, Faccio R, Liu X, Li J, Usmani S, Bachar M, Bab I, Nishimori K, Young LJ, Buettner C, Iqbal J, Sun L, Zaidi M, Zallone A. Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7149-54. PMID: 19369205

8.     Buettner C and Camacho RC. Hypothalamic control of hepatic glucose production and its potential role in insulin resistance. Endocrinol Metab Clin North Am. 2008 Dec;37(4):825-40. NIHMS84775

9.     Osei-Hyiaman D, Liu J, Zhou L, Godlewski G, Harvey-White J, Jeong WI, B├ítkai S, Marsicano G, Lutz B, Buettner C, Kunos G. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest. 2008 Sep;118(9):3160-9. PMCID:2491458

10.     Buettner C, Muse ED, Pocai A, Chen A, Kai S, Chen, L, Harvey-White, J, Kunos, G and Rossetti L. Leptin control adipose tissue endocannabinoids and lipogenesis via central, STAT3 independent pathways. Nat Med. 2008 Jun;14(6):667-75 . PMCID:2671848

11.     Buettner C, Pocai A, Muse ED, Etgen A, Myers M and Rossetti L. The role of Stat3 in the metabolic actions of leptin. Cell Met. 4, July; 2006, 49-60.  PMID: 16814732

12.     Pocai A, Morgan K, Buettner C, Gutierrez-Juarez R, Obici S, Rossetti L. Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes. 2005 Nov;54(11):3182-9. PMID: 16249443

13.   Buettner C, Patel R, Muse ED, Bhanot S,  Monia P, McKay R, Obici S, Rossetti L. Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice. J.Clin.Invest 2005 May; 115:1306-1313. PMCID:1087163

Contact Us

Christoph Buettner MD, PhD
Tel: 212-241-3425
Fax: 212-241-4218
Send e-mail

Atran Berg Laboratory Building
Room 4-23
1428 Madison Avenue
Box 1055
New York, NY 10029